Skip to main content
National Institutes of Health
En español
Search Component
Mega Menu
Home
Research Topics
Research Topics
Addiction Science
Cannabis (Marijuana)
Fentanyl
Harm Reduction
Heroin
HIV
Kratom
Methamphetamine
Opioids
Prevention
Psychedelic and Dissociative Drugs
Psilocybin (Magic Mushrooms)
Syringe Services Programs
Stigma and Discrimination
Tobacco/Nicotine and Vaping
Treatment
Xylazine
More Research Topics
Quick Links
Resources for Parents and Educators
Words Matter: Preferred Language
Commonly Used Drugs Chart
NIDA Publications
Infographics
Multimedia
Research & Training
Research & Training
NIDA Research Programs & Activities
Clinical Research
NIH Policies & Guidance
Research Data, Measures, & Resources
Research Training & Career Development
Resources for Grants & Contracts
Quick Links
HEAL Initiative
NIDA Drug Supply Program
Clinical Trials Stewardship
Fellowships & Grants
International Program
Clinical Resources
NIDAMED: Clinical Resources
For Your Discipline
Health Professions Education
Marijuana and Other Drugs
Opioid Crisis and Pain Management
Screening Tools & Prevention
Treatment
Quick Links
Screening and Assessment Tools Chart
Words Matter - Terms to Use and Avoid When Talking About Addiction
Grants & Funding
Grants & Funding
NIDA Funding Opportunities
Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Programs
Trans-NIH Funding Opportunities
NIDA Office of Acquisitions Contracting
Technology Transfer
Quick Links
Peer Review
Grant Application Forms
Grants & Contract Application Process
NIDA Notice of Special Interest (NOSI)
News & Events
News
News Releases
Nora's Blog
Meeting and Events
NIDA in the News
NIDA Asks
Quick Links
Contact the Press Office
media@nida.nih.gov
301-443-6245
About NIDA
About NIDA
Advisory Boards and Review Groups
Director's Page
Legislative Activities
Organization
Working at NIDA
Quick Links
NIDA Strategic Plan
FY Budget Information
Clinical Trials Network
Frequently Asked Questions
Contact Us
Breadcrumb
Home
Pierre-Paul Rompre
Pierre-Paul Rompre
